Bone anabolic effect of ixazomib - a third generation proteasome inhibitor – in multiple myeloma patients

Marta Diaz-Delcastillo; Gundesen MT; Christian Andersen; Anne Nielsen; Hanne E. H. Møller; Pernille Vinholt; Jon Thor Asmussen; Ida Bruun Kristensen; Charlotte Guldborg Nyvold; Niels Abildgaard; Thomas Andersen; Thomas Lund

doi:10.1016/S2152-2650(22)00366-4

Bone anabolic effect of ixazomib - a third generation proteasome inhibitor – in multiple myeloma patients

Marta Diaz-Delcastillo, Gundesen MT, Christian Andersen, Anne Nielsen, Hanne E. H. Møller, Pernille Vinholt, Jon Thor Asmussen, Ida Bruun Kristensen, Charlotte Guldborg Nyvold, Niels Abildgaard, Thomas Andersen, Thomas Lund

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Article number	P-036
Journal	Clinical Lymphoma Myeloma and Leukemia
Volume	22
Issue number	Suppl.
Pages (from-to)	55
Number of pages	1
ISSN	2152-2650
DOIs	https://doi.org/10.1016/S2152-2650(22)00366-4
Publication status	Published - 2022
Event	19th International Myeloma Society Annual Meeting - Los Angeles, United States Duration: 25. Aug 2022 → 27. Aug 2022

Conference

Conference	19th International Myeloma Society Annual Meeting
Country/Territory	United States
City	Los Angeles
Period	25/08/2022 → 27/08/2022

Documents & Links

10.1016/S2152-2650(22)00366-4

Cite this

Diaz-Delcastillo, M., MT, G., Andersen, C., Nielsen, A., Møller, H. E. H., Vinholt, P., Asmussen, J. T., Kristensen, I. B., Nyvold, C. G., Abildgaard, N., Andersen, T., & Lund, T. (2022). Bone anabolic effect of ixazomib - a third generation proteasome inhibitor – in multiple myeloma patients. Clinical Lymphoma Myeloma and Leukemia, 22(Suppl. ), 55. [P-036]. https://doi.org/10.1016/S2152-2650(22)00366-4

@article{5e5e545bb89745d6a99f4e432ce94352,

title = "Bone anabolic effect of ixazomib - a third generation proteasome inhibitor – in multiple myeloma patients",

author = "Marta Diaz-Delcastillo and Gundesen MT and Christian Andersen and Anne Nielsen and M{\o}ller, {Hanne E. H.} and Pernille Vinholt and Asmussen, {Jon Thor} and Kristensen, {Ida Bruun} and Nyvold, {Charlotte Guldborg} and Niels Abildgaard and Thomas Andersen and Thomas Lund",

year = "2022",

doi = "10.1016/S2152-2650(22)00366-4",

language = "English",

volume = "22",

pages = "55",

journal = "Clinical Lymphoma Myeloma and Leukemia",

issn = "2152-2650",

publisher = "Elsevier",

number = "Suppl. ",

note = "19th International Myeloma Society Annual Meeting, IMS2022 ; Conference date: 25-08-2022 Through 27-08-2022",

}

Diaz-Delcastillo, M, MT, G, Andersen, C, Nielsen, A, Møller, HEH , Vinholt, P, Asmussen, JT, Kristensen, IB , Nyvold, CG , Abildgaard, N , Andersen, T & Lund, T 2022, 'Bone anabolic effect of ixazomib - a third generation proteasome inhibitor – in multiple myeloma patients', Clinical Lymphoma Myeloma and Leukemia, vol. 22, no. Suppl. , P-036, pp. 55. https://doi.org/10.1016/S2152-2650(22)00366-4

TY - ABST

T1 - Bone anabolic effect of ixazomib - a third generation proteasome inhibitor – in multiple myeloma patients

AU - Diaz-Delcastillo, Marta

AU - MT, Gundesen

AU - Andersen, Christian

AU - Nielsen, Anne

AU - Møller, Hanne E. H.

AU - Vinholt, Pernille

AU - Asmussen, Jon Thor

AU - Kristensen, Ida Bruun

AU - Nyvold, Charlotte Guldborg

AU - Abildgaard, Niels

AU - Andersen, Thomas

AU - Lund, Thomas

PY - 2022

Y1 - 2022

U2 - 10.1016/S2152-2650(22)00366-4

DO - 10.1016/S2152-2650(22)00366-4

M3 - Conference abstract in journal

SN - 2152-2650

VL - 22

SP - 55

JO - Clinical Lymphoma Myeloma and Leukemia

JF - Clinical Lymphoma Myeloma and Leukemia

IS - Suppl.

M1 - P-036

T2 - 19th International Myeloma Society Annual Meeting

Y2 - 25 August 2022 through 27 August 2022

ER -